Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 6/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.49 |
| ▸ | AHCY | P23526 | 4/20 | 0.48 |
| ▸ | PI4KA | P42356 | 6/20 | 0.47 |
| ▸ | PI4K2B | Q8TCG2 | 6/20 | 0.47 |
| ▸ | PI4K2A | Q9BTU6 | 6/20 | 0.47 |
| ▸ | PI4KB | Q9UBF8 | 6/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28406876 | 0.98 | ADORA2A (0.50) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| SCHEMBL16485904 | 0.83 | GSK3B (0.48) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| SCHEMBL28113155 | 0.83 | GSK3B (0.51) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| SCHEMBL28406873 | 0.81 | ADORA2A (0.50) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| SCHEMBL28145519 | 0.81 | ADORA2A (0.50) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| SCHEMBL22458325 | 0.81 | FGFR1 (0.45) | GSK3BTDP1ALDH1A1 | |
| SCHEMBL28086747 | 0.81 | ADORA2A (0.48) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| SCHEMBL15297006 | 0.80 | ADCY5 (0.47) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| Acetone SCHEMBL28162073 | 0.80 | CYP3A4 (0.47) | ADORA2AADORA1GSK3BAHCYPI4KA | |
| SCHEMBL385843 | 0.78 | ADORA2A (0.55) | ADORA2AADORA1GSK3BAHCYPI4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039583-B | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2025-03-11 | — | — | CN | claimed |
| CN-119039583-A | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2024-11-29 | — | — | CN | claimed |
| CN-119039583-B | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2025-03-11 | — | — | CN | disclosed |
| CN-119039583-A | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2024-11-29 | — | — | CN | disclosed |
| US-10093674-B2 | Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases | BRANDEIS UNIVERSITY (US) | 2018-10-09 | — | — | US | disclosed |
| US-20180100036-A1 | CLICK NUCLEIC ACID POLYMERS AND METHODS OF USE | UNIV COLORADO REGENTS (US) | 2018-04-12 | — | — | US | disclosed |
| US-20140148410-A1 | Supramolecular Nanofibers and Hydrogels Based on Nucleic Acids Functionalized with Nucleobases | BRANDEIS UNIVERSITY (US) | 2014-05-29 | — | — | US | disclosed |
| CN-103145714-A | Feather weight PNA (pentose nucleic acid) synthesis method | SUZHOU VIVOTIDE BIOTECHNOLOGIES CO LTD | 2013-06-12 | — | — | CN | disclosed |
| WO-2012166706-A2 | SUPRAMOLECULAR NANOFIBERS AND HYDROGELS BASED ON OLIGOPEPTIDES FUNCTIONALIZED WITH NUCLEOBASES | BRANDEIS UNIVERSITY (US) | 2012-12-06 | — | — | WO | disclosed |
| WO-2012166705-A2 | SUPRAMOLECULAR NANOFIBERS AND HYDROGELS BASED ON AMINO ACID-NUCLEOBASE-GLYCOSIDE CONJUGATES | BRANDEIS UNIVERSITY (US) | 2012-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140148410-A1 | Supramolecular Nanofibers and Hydrogels Based on Nucleic Acids Functionalized with Nucleobases | PHAX, PCNA, RBM28 | ADORA2A 1717/4885ADORA1 2410/4885GSK3B 2931/4885 |
| US-10093674-B2 | Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases | PHAX, PCNA, RBM28 | ADORA2A 1717/4885ADORA1 2410/4885GSK3B 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.